Cargando…

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

BACKGROUND: As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvements in delivery of treatment, with the ultimate goal of e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adland, Emily, Jesuthasan, Gerald, Downs, Louise, Wharton, Victoria, Wilde, Gemma, McNaughton, Anna L., Collier, Jane, Barnes, Eleanor, Klenerman, Paul, Andersson, Monique, Jeffery, Katie, Matthews, Philippa C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137907/ https://www.ncbi.nlm.nih.gov/pubmed/30217169 http://dx.doi.org/10.1186/s12879-018-3367-3

Ejemplares similares

Oxford Screening CSF and Respiratory samples (‘OSCAR’): results of a pilot study to screen clinical samples from a diagnostic microbiology laboratory for viruses using Illumina next generation sequencing
por: Sharp, Colin, et al.
Publicado: (2018)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
por: Wang, Tingyan, et al.
Publicado: (2021)

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
por: Downs, Louise O., et al.
Publicado: (2021)

Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era
por: Adland, Emily, et al.
Publicado: (2015)

Ever closer to a prophylactic vaccine for HCV
por: Swadling, Leo, et al.
Publicado: (2013)

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
por: Campbell, Cori, et al.
Publicado: (2020)

HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
por: McNaughton, Anna L., et al.
Publicado: (2019)

Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
por: Campbell, Cori, et al.
Publicado: (2021)

Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen
por: Lumley, Sheila F., et al.
Publicado: (2018)

Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
por: Downs, Louise O., et al.
Publicado: (2020)

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa
por: Jooste, Pieter, et al.
Publicado: (2016)

Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
por: Downs, Louise O., et al.
Publicado: (2019)

HCV genotype-3a T cell immunity: specificity, function and impact of therapy
por: Humphreys, Isla S, et al.
Publicado: (2012)

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
por: Mokaya, Jolynne, et al.
Publicado: (2020)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Paediatric PARV4 infection in South Africa: relationship to age, maternal PARV4 status, and HIV infection
por: Matthews, Philippa, et al.
Publicado: (2014)

Defining the key intrahepatic gene networks in HCV infection driven by sex
por: Marchi, Emanuele, et al.
Publicado: (2023)

PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort
por: Sharp, Colin P., et al.
Publicado: (2017)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
por: von Delft, Annette, et al.
Publicado: (2018)

Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?
por: Pley, Caitlin, et al.
Publicado: (2022)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
por: Pley, Caitlin M, et al.
Publicado: (2021)

Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents
por: Jay, Cecilia, et al.
Publicado: (2023)

Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana
por: Matthews, Philippa C., et al.
Publicado: (2015)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?
por: Campbell, Cori, et al.
Publicado: (2023)

HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults
por: Matthews, Philippa C., et al.
Publicado: (2016)

Human Parvovirus 4 Infection among Mothers and Children in South Africa
por: Matthews, Philippa C., et al.
Publicado: (2015)

Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors
por: O'Hara, Geraldine, et al.
Publicado: (2020)

Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
por: McNaughton, Anna L., et al.
Publicado: (2020)

Polymorphisms predicting phylogeny in hepatitis B virus
por: Lourenço, José, et al.
Publicado: (2022)

ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens
por: Bonsall, David, et al.
Publicado: (2015)

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design
por: von Delft, Annette, et al.
Publicado: (2016)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
por: Mokaya, Jolynne, et al.
Publicado: (2019)

HCV–HIV Coinfection: Simple Messages from a Complex Disease
por: Klenerman, Paul, et al.
Publicado: (2007)

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
por: Innes, Hamish, et al.
Publicado: (2021)

Methodologies for the Analysis of HCV-Specific CD4(+) T Cells
por: Lokhande, Megha U., et al.
Publicado: (2015)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
por: Swadling, Leo, et al.
Publicado: (2016)

SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
por: Ward, Victoria, et al.
Publicado: (2022)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i8fsia564n0ii30uhn3greg3vc